FDA Inspection 1116753 — Hovione LLC

Hovione LLC — FEI 3006106736

The FDA completed an inspection of Hovione LLC on January 22, 2020 in East Windsor, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 22, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
East Windsor, NJ (United States)